Application of Healthcare ‘Big Data’ in CNS Drug Research: The Example of the Neurological and mental health Global Epidemiology Network (NeuroGEN)

Sep-20

Database General Analysis Mental Health Neurology

AUTHORS : Dr Jenni Ilomäki, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Melbourne VIC 3052, Australia – Email: Jenni.Ilomaki@monash.edu – Progile: https://research.monash.edu/en/persons/jenni-ilomaki OR Professor Ian C.K. Wong, Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, L02-56, 2/F, Laboratory Block, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong – Email: wongick@hku.hk – Profile: https://www.pharma.hku.hk/en/Our-People/Professoriate/Head/Professor-Ian-CK-WONG/Professor-Ian-CK-WONG-Profile

JOURNAL : CNS Drugs

REFERENCE: 34(9):897-913

DOI : 10.1007/s40263-020-00742-4

Application of Healthcare ‘Big Data’ in CNS Drug Research: The Example of the Neurological and mental health Global Epidemiology Network (NeuroGEN)

More publications

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis

Machine learning prediction algorithms for 2- , 5- and 10-year risk of Alzheimer’s, Parkinson’s and dementia at age 65: a study using medical records from France and the UK General Practitioners

Maternal perinatal anxiety and infant primary care use in 1998–2016: a UK cohort study